Contact: mkiwright@ucdavis.edu
Titles: Staff Pharmacist II, Adult Infusion Center, UC Davis Health
Education: PharmD., University of California, San Francisco, 2018
Post-graduate Training:
Research Interests:
Palliative care, pain management, antimicrobial prophylaxis in hematologic malignancy, management of medication hypersensitivity/anaphylaxis
Practice Philosophy:
I am a believer in experiential learning—in the field of oncology, we rely on prior experience to incorporate new clinical information into therapy plans. A clinical team that embraces effective communication is important in implementing new treatments for our patients. At the core of the field is a patient population that has been diagnosed with an illness that impacts all aspects of life. Consideration of access to care, home support, and palliative care must be given to each patient. I aim to grow as a well-rounded clinician that is able to assist in all aspects of patient care.
Bio:
Dr. Michael Wright is an oncology pharmacist with the infusion center at UC Davis Health. His pharmacy career began in undergrad at UCLA, where he spent his weekends coordinating medication delivery for the hospital’s pharmacy department. After graduating from the UCSF School of Pharmacy in 2018, he went on to complete a PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Residency at UC Davis Health.
Following completion of his Oncology PGY2 program, he accepted a position with the infusion center at the UC Davis Health Comprehensive Cancer Center. He is an active member of the Oncology Subcommittee, through which he contributed to the development of the Chemotherapy Desensitization Work Group.
Dr. Wright enjoys working with learners—his personal experience developing as a pharmacist at UCD enables him to serve as resource for both clinical and research-related topics. He was awarded a UCSF School of Pharmacy Dean’s Apple Teaching Award in 2017. As a researcher, his evaluation of discharge opioid practices earned a publication in the Journal of Burn Care & Research in 2020.